181
Participants
Start Date
December 31, 2016
Primary Completion Date
May 31, 2018
Study Completion Date
May 31, 2018
Teriparatide (PF708)
Subcutaneous injection
Teriparatide (Forteo)
Subcutaneous injection
Altoona Center for Clinical Research, Duncansville
Pennsylvania Regional Center for Arthritis & Osteoporosis Research, Wyomissing
Spectrum Medical, Danville
Atlanta Research Center, Atlanta
OB-GYN Associates of Mid-Florida, Leesburg
Radiant Research, Birmingham
The Orthopaedic Group, Mobile
Radiant Research, Akron
Radiant Research, Cincinnati
Lillestol Research, Fargo
Radiant Research, Chicago
Radiant Research, Bridgeton
Radiant Research, Papillion
Radiant Research, Plano
Radiant Research, Dallas
Radiant Research, San Antonio
Radiant Research, San Antonio
Radiant Research, Colorado Springs
Radiant Research, Phoenix
Radiant Research, Mesa
Radiant Research, Chandler
SunValley Arthritis Center, Peoria
New Mexico Clinical Research & Osteoporosis Center, Albuquerque
Radiant Research, Henderson
Radiant Research, Las Vegas
Radiant Research, Puyallup
Lead Sponsor
Pfenex, Inc
INDUSTRY